Biosimilar of Remicade Market Report

Global and Region Biosimilar of Remicade Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：172
  • REPORT CODE：GMM946662
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product. 

    The report details the trend, potential and market size of Biosimilar of Remicade market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Biosimilar of Remicademarket, defines the market attractiveness level of Biosimilar of Remicade market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Biosimilar of Remicade industry, describes the types of Biosimilar of Remicade market, the applications of major players and the market size, and deeply analyzes the current situation of the global Biosimilar of Remicade market and the development prospects and opportunities of Biosimilar of Remicade industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Biosimilar of Remicade market in Chapter 13.

    By Player:

    • Hospira

    • Biogen idec Inc

    • Merck Serono (Merck Group)

    • Biocon

    • Celltrion

    • LG Life Sciences

    • ynthon Pharmaceuticals

    • Genentech (Roche Group

    • Novartis (Sandoz)

    By Type:

    • 100mg/10ml

    • 500mg/50ml

    By End-User:

    • Blood Disorders

    • Oncology Diseases

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Biosimilar of Remicade Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Biosimilar of Remicade Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Biosimilar of Remicade Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Biosimilar of Remicade Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Biosimilar of Remicade Market Analysis and Outlook to 2022

    • 7.1 Global Biosimilar of Remicade Consumption (2017-2022)

    • 7.2 United States Biosimilar of Remicade Consumption (2017-2022)

    • 7.3 Europe Biosimilar of Remicade Consumption (2017-2022)

    • 7.4 China Biosimilar of Remicade Consumption (2017-2022)

    • 7.5 Japan Biosimilar of Remicade Consumption (2017-2022)

    • 7.6 India Biosimilar of Remicade Consumption (2017-2022)

    • 7.7 South Korea Biosimilar of Remicade Consumption (2017-2022)

    8 Region and Country-wise Biosimilar of Remicade Market Analysis and Outlook to 2028

    • 8.1 Global Biosimilar of Remicade Consumption Forecast (2022-2028)

    • 8.2 United States Biosimilar of Remicade Consumption Forecast (2022-2028)

    • 8.3 Europe Biosimilar of Remicade Consumption Forecast (2022-2028)

    • 8.4 China Biosimilar of Remicade Consumption Forecast (2022-2028)

    • 8.5 Japan Biosimilar of Remicade Consumption Forecast (2022-2028)

    • 8.6 India Biosimilar of Remicade Consumption Forecast (2022-2028)

    • 8.7 South Korea Biosimilar of Remicade Consumption Forecast (2022-2028)

    9 Global Biosimilar of Remicade Market Outlook by Types and Applications to 2022

    • 9.1 Global Biosimilar of Remicade Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 100mg/10ml Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 500mg/50ml Consumption and Growth Rate (2017-2022)

    • 9.2 Global Biosimilar of Remicade Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Blood Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oncology Diseases Consumption and Growth Rate (2017-2022)

    10 Global Biosimilar of Remicade Market Outlook by Types and Applications to 2028

    • 10.1 Global Biosimilar of Remicade Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global 100mg/10ml Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global 500mg/50ml Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Biosimilar of Remicade Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Oncology Diseases Consumption Forecast and Growth Rate (2022-2028)

    11 Global Biosimilar of Remicade Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Biosimilar of Remicade Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Biosimilar of Remicade Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Biosimilar of Remicade Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Biosimilar of Remicade Market Competitive Analysis

    • 14.1 Hospira

      • 14.1.1 Hospira Company Details

      • 14.1.2 Hospira Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Hospira Biosimilar of Remicade Product and Service

    • 14.2 Biogen idec Inc

      • 14.2.1 Biogen idec Inc Company Details

      • 14.2.2 Biogen idec Inc Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Biogen idec Inc Biosimilar of Remicade Product and Service

    • 14.3 Merck Serono (Merck Group)

      • 14.3.1 Merck Serono (Merck Group) Company Details

      • 14.3.2 Merck Serono (Merck Group) Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Merck Serono (Merck Group) Biosimilar of Remicade Product and Service

    • 14.4 Biocon

      • 14.4.1 Biocon Company Details

      • 14.4.2 Biocon Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Biocon Biosimilar of Remicade Product and Service

    • 14.5 Celltrion

      • 14.5.1 Celltrion Company Details

      • 14.5.2 Celltrion Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Celltrion Biosimilar of Remicade Product and Service

    • 14.6 LG Life Sciences

      • 14.6.1 LG Life Sciences Company Details

      • 14.6.2 LG Life Sciences Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 LG Life Sciences Biosimilar of Remicade Product and Service

    • 14.7 ynthon Pharmaceuticals

      • 14.7.1 ynthon Pharmaceuticals Company Details

      • 14.7.2 ynthon Pharmaceuticals Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 ynthon Pharmaceuticals Biosimilar of Remicade Product and Service

    • 14.8 Genentech (Roche Group

      • 14.8.1 Genentech (Roche Group Company Details

      • 14.8.2 Genentech (Roche Group Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Genentech (Roche Group Biosimilar of Remicade Product and Service

    • 14.9 Novartis (Sandoz)

      • 14.9.1 Novartis (Sandoz) Company Details

      • 14.9.2 Novartis (Sandoz) Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Novartis (Sandoz) Biosimilar of Remicade Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Biosimilar of Remicade

    • Figure Biosimilar of Remicade Picture

    • Table Global Biosimilar of Remicade Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biosimilar of Remicade Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biosimilar of Remicade Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Biosimilar of Remicade Consumption by Country (2017-2022)

    • Figure United States Biosimilar of Remicade Consumption and Growth Rate (2017-2022)

    • Table Europe Biosimilar of Remicade Consumption and Growth Rate (2017-2022)

    • Figure China Biosimilar of Remicade Consumption and Growth Rate (2017-2022)

    • Figure Japan Biosimilar of Remicade Consumption and Growth Rate (2017-2022)

    • Figure India Biosimilar of Remicade Consumption and Growth Rate (2017-2022)

    • Figure South Korea Biosimilar of Remicade Consumption and Growth Rate (2017-2022)

    • Figure Global Biosimilar of Remicade Consumption Forecast by Country (2022-2028)

    • Figure United States Biosimilar of Remicade Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Biosimilar of Remicade Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Biosimilar of Remicade Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Biosimilar of Remicade Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Biosimilar of Remicade Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Biosimilar of Remicade Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 100mg/10ml Consumption and Growth Rate (2017-2022)

    • Figure Global 500mg/50ml Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global 100mg/10ml Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 500mg/50ml Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Biosimilar of Remicade Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Biosimilar of Remicade Export by Region (Top 5 Countries) (2017-2028)

    • Table Hospira (Foundation Year, Company Profile and etc.)

    • Table Hospira Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hospira Biosimilar of Remicade Product and Service

    • Table Biogen idec Inc (Foundation Year, Company Profile and etc.)

    • Table Biogen idec Inc Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen idec Inc Biosimilar of Remicade Product and Service

    • Table Merck Serono (Merck Group) (Foundation Year, Company Profile and etc.)

    • Table Merck Serono (Merck Group) Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Serono (Merck Group) Biosimilar of Remicade Product and Service

    • Table Biocon (Foundation Year, Company Profile and etc.)

    • Table Biocon Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Biosimilar of Remicade Product and Service

    • Table Celltrion (Foundation Year, Company Profile and etc.)

    • Table Celltrion Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Biosimilar of Remicade Product and Service

    • Table LG Life Sciences (Foundation Year, Company Profile and etc.)

    • Table LG Life Sciences Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

    • Table LG Life Sciences Biosimilar of Remicade Product and Service

    • Table ynthon Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table ynthon Pharmaceuticals Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

    • Table ynthon Pharmaceuticals Biosimilar of Remicade Product and Service

    • Table Genentech (Roche Group (Foundation Year, Company Profile and etc.)

    • Table Genentech (Roche Group Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech (Roche Group Biosimilar of Remicade Product and Service

    • Table Novartis (Sandoz) (Foundation Year, Company Profile and etc.)

    • Table Novartis (Sandoz) Biosimilar of Remicade Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis (Sandoz) Biosimilar of Remicade Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US